Table II.
Target | 5′-3′ sequence |
---|---|
BMP2 | F AATGCAAGCAGGTGGGAAAG |
BMP2 | R GCTGTGTTCATCTTGGTGCA |
CDH2 | F AATCGTGTCTCAGGCTCCAA |
CDH2 | R TGCCTTCCATGTCTGTAGCT |
FN1 | F ACAGCTCATCCGTGGTTGTA |
FN1 | R TCTTGGTGGGCTGACATTCT |
HMOX1 | F CTTTCAGAAGGGCCAGGTGA |
HMOX1 | R AAGTAGACAGGGGCGAAGAC |
HSPG2 | F CCACTTCTACCTGGAGCACA |
HSPG2 | R TGAAGTCATCGGGTTGGTCA |
SPARC | F GTTTGAGAAGGTGTGCAGCA |
SPARC | R TGTATTTGCAAGGCCCGATG |
COL-II | F TCCAGATGACCTTCCTACGC |
COL-II | R CTTCTTGAGGTTGCCAGCTG |
OCN | F GTGCAGAGTCCAGCAAAGGT |
OCN | R TCAGCCAACTCGTCACAGTC |
OPN | F TTGCAGTGATTTGCTTTTGC |
OPN | R GCCACAGCATCTGGGTATTT |
RUNX2 | F TGTCATGGCGGGTAACGAT |
RUNX2 | R AAGACGGTTATGGTCAAGGTGAA |
BMP2, bone morphogenetic protein 2; CDH2, N-Cadherin; FN1, fibronectin; HMOX1, heme oxygenase 1; HSPG2, heparin sulfate proteoglycan 2; SPARC, secreted protein acidic and cysteine rich; COL-II, Collagen type 2; OCN, osteocalcin; OPN, osteopontin; RUNX2, Runt-related transcription factor 2; F, forward; R, reverse.